BioMedNewsBreaks – Predictive Oncology (NASDAQ: POAI) Announces Q3 Numbers, Company Updates
Nov 17, 2020
Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, has released its financial results and provided business updates for the quarter ended Sept. 30, 2020. The report included a note that revenues of $0.5 million were level with the third quarter of last year, primarily driven through the sale of Predictive Oncology’s proprietary STREAMWAY product line. In addition, the company’s subsidiary, Soluble Biotech, moved into a new office and lab space and installed new equipment. POAI also signed its first contract with a pharmaceutical company for protein expression and solubility studies, and licensed 71 additional unique ovarian cancer cell lines from Ximbio, the world’s largest nonprofit dedicated to life science reagents of all kinds. “During the third quarter, we continued our work of laying a foundation for our precision medicine business,” said Predictive Oncology CEO Carl Schwartz, MD, in the press release. “We are making steady progress in our Helomics division with the launch of a restructured clinical test offering to clinicians for ovarian cancer. Our project with UPMC-Magee Womens Hospital, analyzing the genomic and drug response profiles of women with ovarian cancer to build predictive models’ terms of therapy response, is close to completion. We are also in discussions with several pharmaceutical companies about partnerships that will monetize our efforts. . . .Management continues to focus the majority of its resources on the company’s primary mission of applying artificial intelligence to precision medicine and to drug discovery. Our approach and the mediums used to replace rats and mice in preliminary cancer studies are working in three of our operating subsidiaries, Helomics, TumorGenesis and Soluble Biotech.”
To view the full press release, visit https://ibn.fm/Q6jl5
About Predictive Oncology Inc.
Predictive Oncology operates through three segments (domestic, international and other), which contain four subsidiaries; Helomics, TumorGenesis, Skyline Medical and Soluble Biotech. Helomics applies artificial intelligence to its rich data gathered from patient tumors to both personalize cancer therapies for patients and drive the development of new targeted therapies in collaborations with pharmaceutical companies. TumorGenesis Inc. specializes in media that help cancer cells grow and retain their DNA/RNA and proteomic signatures, providing researchers with a tool to expand and study cancer cell types found in tumors of the blood and organ systems of all mammals, including humans. Skyline Medical markets its patented and FDA cleared STREAMWAY System, which automates the collection, measurement and disposal of waste fluid, including blood, irrigation fluid and others, within a medical facility, through both domestic and international divisions. Soluble Biotech is a provider of soluble and stable formulations for proteins including vaccines, antibodies, large and small proteins and protein complexes. For more information about the company, please visit www.Predictive-Oncology.com.
NOTE TO INVESTORS: The latest news and updates relating to POAI are available in the company’s newsroom at http://ibn.fm/POAI
About BioMedWire
BioMedWire (BMW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) BioMedNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. BMW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.
To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
For more information please visit https://www.BioMedWire.com
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer
BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
[email protected]
BioMedWire is part of the InvestorBrandNetwork
More News
US, Japan and South Korea launch economic-security talks before Xi summit
The United States, Japan and South Korea announced a new economic-security consultation and reinforced their support for stability across the Taiwan Strait on Monday, sending a coordinated message on two of Beijing’s most sensitive issues just days before Chinese President Xi Jinping’s summit with US President Donald Trump. US Secretary of State Marco Rubio, Japanese Foreign Minister Motegi Toshimitsu and South Korean Foreign Minister Cho Hyun unveiled the initiative after meeting on the...
India Sends Strong Squad To BWF World Junior Championships 2026
India sends an 18-member badminton squad to the BWF World Junior Championships 2026 in Cairo, led by Tanvi Patri, Shaina Manimuthu, and Dev Ruparelia.
Asian Games 2026 India Full Schedule, September 22: Complete List Of Events And Timings
Indian athletes compete in various events at the Asian Games on Tuesday, September 22, including badminton, boxing, cricket, and hockey.
India Loses Lead At Chess Olympiad After Defeat To Uzbekistan
India lost 1.5-2.5 to Uzbekistan in the 46th Chess Olympiad, losing their lead in the open section. Nihal Sarin was defeated, while other games were drawn.
Controversy Hits Indian Rowing Team At Asian Games: Players Not Eating Food After Event Changes
Indian rowing team faces controversy at Asian Games. Rowers allege being moved from events, replaced by reserves, causing distress.
Chhattisgarh govt launches portal for verification of private university degrees
Students, parents, employers and other institutions will be able to check academic credentials without having to approach individual universities for verification
Asian Games 2026 Medals Race Day 2 Update: India Slip To 12th, China At Top
India doubled its medal count to six at the 20th Asian Games, securing silver in shooting and bronze in MMA. China and Japan lead the standings.
Japanese logistics provider Nippon Express looks at States like UP for next expansion
After Japan, the US, Europe and other parts of Asia, Nippon Express Group is now trying make a “big team in India”, says Katsuhito Kobayashi, Executive Officer, South Asia & Oceania Region
First ladies step forward as Trump lays on rare honours for Xi
US first lady Melania Trump is set to lead key cultural diplomacy events during the coming official state visit by Chinese President Xi Jinping and his wife, Peng Liyuan, marking their first visit to the White House since 2015. According to an official itinerary released by the first lady’s office, the three-day visit, scheduled from September 23 to 25, will feature extensive ceremonial honours alongside dedicated cultural exchanges highlighting Sino-American relations. Melania will join US...
How head-of-state diplomacy steers China-US ties toward stability
Chinese President Xi Jinping will pay a state visit to the United States from September 23 to 25 at the invitation of US President Donald Trump. It will be the second meeting between the two heads of state within half a year, following Trump's state visit to China in May. Detailing Xi's upcoming visit on Monday, Chinese Foreign Ministry spokesperson Guo Jiakun said the exchange of visits marks a historic milestone.
Indian lab in international effort to develop non-animal alternatives for inhalation toxicity tests
Pilot study done by PETA Science Consortium International, US Environmental Protection Agency, & Belgium’s Flemish Institute for Technological Research
23rd China-ASEAN Expo concludes in Nanning, China's Guangxi
The 23rd China-ASEAN Expo has concluded in Nanning City, in south China's Guangxi Zhuang Autonomous Region.
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.